These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17498948)

  • 1. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
    Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally efficacious NR2B-selective NMDA receptor antagonists.
    Claiborne CF; McCauley JA; Libby BE; Curtis NR; Diggle HJ; Kulagowski JJ; Michelson SR; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
    Bioorg Med Chem Lett; 2003 Feb; 13(4):697-700. PubMed ID: 12639561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
    Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist.
    Suetake-Koga S; Shimazaki T; Takamori K; Chaki S; Kanuma K; Sekiguchi Y; Suzuki T; Kikuchi T; Matsui Y; Honda T
    Pharmacol Biochem Behav; 2006 May; 84(1):134-41. PubMed ID: 16764916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
    Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
    Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression.
    Barton ME; White HS
    Epilepsy Res; 2004 Mar; 59(1):1-12. PubMed ID: 15135162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists.
    Beinat C; Banister S; Moussa I; Reynolds AJ; McErlean CS; Kassiou M
    Curr Med Chem; 2010; 17(34):4166-90. PubMed ID: 20939817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
    Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifenprodil induced antinociception and decreased the expression of NR2B subunits in the dorsal horn after chronic dorsal root ganglia compression in rats.
    Zhang W; Shi CX; Gu XP; Ma ZL; Zhu W
    Anesth Analg; 2009 Mar; 108(3):1015-20. PubMed ID: 19224818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
    Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
    J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
    Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
    Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
    Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
    McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
    J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.